SYM 1 Biomarkers for the Diagnosis of Cardiovascular Diseases SYM 2 Diagnostic Challenges in Liver Disease YR 1 Clinical Chemistry 2010 and Beyond: Opportunities and Challenges for the Next Decade SYM 3 Tumor Markers in Cancer IFCC 1 IFCC EMD/CPD Joint Symposium: ELearning and Distance Education in Clinical Chemistry and Laboratory Medicine SYM 4 Kidney Diseasy – Acute and Chronic DGKL 1 Role of Non-Medical Scientists in the Medical Laboratory (DGKL) WS 1 Reporting HBA1C for Monitoring and Diagnosis: The Devils's in the Detail SYM 5 From Bench to Bedside in Autoimmunity SYM 6 Diabetes WS 2 Emerging Infections at AFCB Countries EFCC 1 How to Assess the Clinical Effectiveness of Laboratory DGKL 2 Laboratory Medicine – Quo vadis? Conditions, Structure and Developmental Trends in Europe INT 2 Pitfalls in the Hemostasiologic Diagnostics: Clinical Cases SYM 7 Pharmacogenetics and Pharmagocenomics YR 2 Infectious Diseases WS 3 Oxidative Stress in Diabetes Mellitus SYM 8 Infectious Diseases IFCC 2 Biobanking and Laboratory Medicine: Two Resources for Modern Health Care SYM 9 Haematology and Anaemia WS 4 Update on Cardiac Troponin – Clinical and Laboratory Issues SYM 10 Diagnostic Use and Value of Function Test in Endocrinology SYM 11 Point of Care Testing – Practical Aspects WS 5 Lessons from the Asian-Pacific Multicenter Reference Interval Study EFCC 2 Accreditation Should Be Focused on More Than Well Organized Examinations With the Laboratory DGKL 4 Quality Management according to the German Rilibaek: An International Perspective WS 6 The 2009 Influenza Pandemic – Lessons Learned SYM 12 Biomarkers in Acute and Chronic Brain Diseases YR 3 Developments in Clinical Laboratory Practice WS 7 Clinical Pharmacogenetics SYM 13 Prenatal and Neonatal Screening IFCC 3 Standardization in Molecular Diagnostics SYM 14 Allergy Diagnostics DGKL 5 Development of a Transcripting, Proteomic and Metabolomic Database for Human Blood Cells WS 8 Molecular Diagnosis of Infection SYM 15 New Developments in Haemostasiology SYM 16 Contribution of Laboratory Medicine in Leukaemia WS 9 What Papers Will Be Preferred in the Future Related to Laboratory Medicine? Editors Point of View EFCC 3 A Scientific Approach to the Post-Analytical Phase DGKL 6 Research Funding by the Foundation of Pathobiochemistry and Molecular Diagnostics of the DGKL – 10 Years on INT 1 Challenges at the Clinical Interfaces SYM 17 New Strategies in Molecular Diagnostic SYM 18 Standardization and Quality Control Issues in Emerging and Developing Countries WS 10 Standardisation of Complex Analyte Measurements: The Clinbiotrace Project SYM 19 Current Challenges in the Pediatric Laboratory EFCC 4 Standardization of the Pre-Analytical Phase for Markers SYM 20 Vitamin D: Myth or Magic IFCC-WASPaLM WS Chronic Kidney Disease – Developing a National Testing Program WS 11 Biomarkers of Acute and Neurodegenerative Brain Damages SYM 21 New Technologies in Clinical Application SYM 22 Intertwining Emergency Medicine and Laboratory Medicine WS 12 Joint Session with IAT DMCT Trends in Therapeutic Drug Monitoring: Personalized Immunosuppression IFCC 4 Traceability, Standardisation, Harmonisation: Concepts and Implementation WS 13 Vitamin Deficiency in Elderly People: Diagnosis, Prevention and Effect on Age-Related Diseases WS 14 Novel Insights in Iron Metabolism: Implications for Diagnostic Medicine

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B65 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000B65 | SxmlIndent | more

{{Explor lien
   |wiki=    Wicri/Sarre
   |area=    MusicSarreV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:6E8257682F7E06D361C827C0062CE31D9BAA725D
   |texte=   Symposium Abstracts
}}